N'-((Dimethylamino)methylene)-N,N-dimethylformohydrazonamide, 95.0%, 250mg

7-amino-5-(2-chlorophenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile, 250mg

3-Bromo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine, 98%, 5g

(S)-1-(tert-Butoxycarbonyl)-3,3-dimethylazetidine-2-carboxylic acid, 97%, 500mg

1-(2-Cyclopropylthiazol-4-yl)ethan-1-one, 97%, 2.5g

4-Ethoxy-2-nitro-phenylamine, 95.0%, 25g

5-Bromo-3-chloro-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g

3-(Dimethylamino)benzoic acid, 97.0%, 100g

[1,2,4]Triazolo[1,5-a]pyrimidin-7-ol, 95.0%, 500mg

Dispensadores Dispensette® S Análogo de análisis de trazas Sin válvula de retorno, Platino-iridio, sin RDV, 1 pieza

N-Benzoyl-L-glutamic Acid>98.0%(HPLC)(T)25g

Incubadora Heratherm Protocol series Protocolo general con convección natural, 194 l, IGS180, 1 pieza

6-(1H-Pyrazol-1-yl)-3-pyridinemethanamine, 95+%, 250mg